![Rashed Dewan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rashed Dewan
Geen lopende functies
Vermogen: 635 558 $ op 31-07-2026
Profiel
Mr. Rashed Dewan was previously employed as a Controller by Profound Medical, Inc. and a Chief Financial Officer by Profound Medical Corp.
He received his undergraduate degree from the University of Southern California.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 24-06-2026 | 86.119 ( 0,24% ) | 635 558 $ | 31-07-2026 |
Eerdere bekende functies van Rashed Dewan
| Bedrijven | Functie | Einde |
|---|---|---|
| PROFOUND MEDICAL CORP. | Financieel Directeur/CFO | 14-08-2026 |
Profound Medical, Inc.
 Profound Medical, Inc. Medical SpecialtiesHealth Technology Develops and commercializes a unique, minimally invasive treatment for prostate cancer | Comptroller/Controller/Auditor | - |
Opleiding van Rashed Dewan
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
22
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Develops and commercializes a unique, minimally invasive treatment for prostate cancer | Health Technology |
Profound Medical Corp.
 Profound Medical Corp. Medical SpecialtiesHealth Technology Develops and markets medical devices focused on prostate cancer | Health Technology |
